Patrick Forde, Professor at The Johns Hopkins University, shared on X:
”Outstanding manuscript now in Nature from Drs. Tina Cascone, M. Provencio and colleagues. Setting the bar for translational correlates in phase 3 cancer trials.
Use of liquid biomarkers of systemic therapy is coming soon in early stage cancer!”
Title: Biomarkers of nivolumab benefit in resectable non-small cell lung cancer
Authors: Tina Cascone, Mark M. Awad, Jonathan D. Spicer, Jie He, Shun Lu, Fumihiro Tanaka, Robin Cornelissen, Lubos B. Petruzelka, Yang Gao, Jean-Louis Pujol, Hiroyuki Ito, Ludmila de Oliveira Muniz Koch, Tudor-Eliade Ciuleanu, Lin Wu, Sabine Bohnet, Yasutaka Watanabe, Janis M. Taube, Julie Stein Deutsch, Cinthya Coronado Erdmann, Stephanie Meadows-Shropshire, Jaclyn Neely, Virginia Ip, Yu-Han Hung, Padma Sathyanarayana, Sumeena Bhatia, Katherine Chu, Steven I. Blum, Stefano Lucherini, Nathanial Eddy, Akshay Yadav, Mariano Provencio
Other articles featuring Patrick Forde on OncoDaily.